ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
Dr. Reddy’s Laboratories out-licenses DFD-06 to Encore Dermatology
August 30, 2017Encore will be responsible for the commercialisation of DFD-06 in the United States. -
Dr. Reddy's Laboratories Announces the Out-Licensing of DFD-06 to Encore Dermatology
August 23, 2017Dr. Reddy’s Laboratories has out-licensed the future development, manufacturing, and commercialization rights of DFD-06, a topical high potency steroid, to Encore Dermatology. The drug is intended to be used for treatment of moderate to severe plaque psor -
DRL out-licenses DFD-06 to Encore Dermatology
August 23, 2017The drug is intended to be used for treatment of moderate to severe plaque psoriasis.
Pharma Sources Insight January 2025
